back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 14:14 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
| Filed 2025-03-20 12:34 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
| Filed 2025-03-20 12:33 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
150,000 | |
| Filed 2024-12-10 14:09 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
112,500 | |
| Filed 2024-12-10 14:08 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
| Filed 2024-12-02 19:32 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+75,000 vol |
75,000 | |
| Filed 2024-12-02 19:31 Tx date 2022-06-24 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-02 19:31 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-75,000 vol |
75,000 | |
| Filed 2024-03-01 14:44 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-01 14:44 Tx date 2022-06-24 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-25 16:35 Tx date 2022-07-13 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+300,000 vol $0.10 each |
300,000 | |
| Filed 2022-07-25 16:33 Tx date 2022-06-24 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|